Overview
Rongying Zhu practices practicing medicine in Shanghai, China.
Their clinical expertise encompasses Cerebral Hypoxia, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Retinoblastoma.
They are actively involved in clinical research, co-authoring 32 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Rongying Zhu
Is Rongying Zhu a top-rated expert for Cerebral Hypoxia?
MediFind is an objective health platform that identifies experts based on real-world data. Rongying Zhu is classified as an Experienced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Rongying Zhu participate in research or clinical trials?
Yes. Rongying Zhu has published 32 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Rongying Zhu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- CardiomyopathyZhu isExperienced. Learn about Cardiomyopathy.
- Cerebral HypoxiaZhu isExperienced. Learn about Cerebral Hypoxia.
- Lung CancerZhu isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- RetinoblastomaZhu isExperienced. Learn about Retinoblastoma.